• 대한한방내과학회지
• /
• 제27권4호
• /
• pp.895-904
• /
• 2006

Objectives : In the present study, the author intended to investigate whether two oriental medical prescriptions named Socheongryongtang-ga-seoggo (SCTS) and Prescription D (P-D) significantly affect mucin release from cultured hamster tracheal surface epithelial (HTSE) cells. Materials and Methods : Confluent HTSE cells were metabolically radiolabeled with 3H-glucosamine for 24 hrs and chased for 30 min in the presence of SCTS or P-D to assess the effect of each agent on 3H-mucin release. Possible cytotoxicities of each agent were assessed by measuring lactate dehydrogenase (LDH) release. Also, the effects of SCTS and P-D on contractility of isolated tracheal smooth muscle were investigated. Results : SCTS did not affect mucin release from cultured HTSE cells, without cytotoxicity. However, P-D significantly increased mucin release from cultured HTSE cells. with significant cytotoxicity. SCTS inhibited Ach-induced contraction of isolated tracheal smooth muscle. P-D also inhibited Ach-induced contraction of isolated tracheal smooth muscle. Conclusions : The author suggests that the effects of SCTS and P-D with their components should be further investigated and it is valuable to find, from oriental medical prescriptions, novel agents which might regulate mucin secretion from airway goblet cells.

• 한국임상약학회지
• /
• 제32권3호
• /
• pp.185-190
• /
• 2022

Background: Denosumab (Prolia®) is administered every 6 months for osteoporosis treatment. Co-administration of calcium and vitamin D is required to minimize hypocalcemia risk. We evaluated clinical outcomes based on the administration interval of denosumab and co-prescription with calcium-vitamin D combination products. Methods: A retrospective study was conducted using electronic medical records from 668 patients who started denosumab therapy between January 1 and December 31, 2018, at Seoul National University Bundang Hospital. Clinical outcomes, as measured by changes in T-score, were evaluated by the intervals and concurrent prescriptions with calcium-vitamin D combination products. Results: Of the 668 patients, 333 patients met the eligibility criteria. These patients were divided into two groups based on appropriateness of the administration interval: "Appropriate" (304 patients, 91.3%) and "Inappropriate" (29 patients, 8.3%). T-score changes were significantly higher in the "Appropriate" than in the "Inappropriate" group (0.30±0.44 vs. 0.13±0.37, p=0.048). At the beginning of the treatment, 221 patients (66.4%) were prescribed calcium-vitamin D combination products, but the changes in T-scores were not significantly different by the prescription status of the product (0.29±0.46 vs. 0.28±0.38, p=0.919). Conclusion: T-scores were significantly improved in patients with appropriate administration intervals. No significant changes in T-scores were observed by the prescription status with calcium-vitamin D combination products. For optimal treatment outcomes, prescribers should encourage adherence to the approved prescription information on dosage and administration, and pharmacists should provide medication counseling for patients.

• 한국안광학회지
• /
• 제18권4호
• /
• pp.357-363
• /
• 2013

목적: 실내수영장에서 도수 수경 착용에 따른 주관적 만족도 평가와 실내 검사실 및 수중에서의 시력을 비교하고자 한다. 방법: 실험에 참여한 대상자는 평균나이가 $22{\pm}1.54$세인 15명의 대학생이었으며, 오른쪽 눈과 왼쪽 눈의 평균 굴절이상은 각각 RE: S-1.67 D/C-0.40 D, LE: S-1.70D/C-0.37 D이었다. 모든 참여자는 기초적인 안과검사를 마쳤으며, 굴절이상을 교정하기 위한 콘택트렌즈 착용이 가능하고 수영이 가능한 자로 한정하였다. 모든 피실험자의 굴절이상은 콘택트렌즈를 이용하여, 정시상태로 교정을 하였다. 난시가 인위적으로 유발된 원주도수 수경(C+1.50 D, Ax $90^{\circ}$)을 착용하였을 때와 도수가 없는 수경을 착용하였을 때 시력, 안정피로, 그리고 수영장 주위를 걸을 때의 균형감각에 대한 주관적인 만족도 평가를 설문지를 이용하여 실시하였다. 시력 평가는 처방 S+3.00 D ~ S-3.00 D까지 0.50 D단위로 준비된 서로 다른 도수의 수경을 무작위의 순서로 착용한 상태에서 수영장내의 수중과 실내의 검사실에서 ETDRS 시표를 사용하여 측정하였다. 결과: 난시가 인위적으로 유발된 상태에서는 시력, 안정피로, 균형감각에 대한 3가지 만족도가 모두 유의하게 저하되는 것으로 나타났다. 서로 다른 도수의 수경을 착용하였을 때 시력은 유의하게 영향을 받는 것으로 나타났으나(p<0.05), 실내 검사실과 수중에서 측정된 시력의 차이는 없었다(p=0.173). 일부 도수 수경(+3.00, +1.00, +0.50, 0, -1.00, -2.00 D)에서는 실내 검사실에서 측정된 시력이 수중에서 측정된 시력보다 향상된 것으로 나타났다. 결론: 수중에서 수경을 착용하는 것은 시력을 저하시킬 수 있지만 저하되는 시력의 정도는 스넬렌 시력기준 1라인 이내 차이로써 실제 임상에서는 거의 영향이 없을 정도로 적은 수준이었다. 하지만 난시의 미교정은 시각적 만족도에 영향을 미치는 것으로 나타났으므로, 수영장의 미끄러운 환경을 고려하였을 때 안전사고의 위험이 내재한다고 할 수 있다. 따라서 도수 수경의 도수의 정확성과 더불어 난시의 교정이 필요하다고 할 수 있다.

• 대한본초학회지
• /
• 제23권4호
• /
• pp.135-147
• /
• 2008

Objectives: Oriental pear was used as traditional remedies for respiratory diseases like cough and asthma etc. The purpose of this study was to observe the effects of preventing asthma by the combination of phenolic compound extracted from pear and herbal drugs. Methods: In order to study the effects of preventing asthma by the combination of phenolic compound extracted from pear and herbal drugs(Platycodon grandiflorum, Prunus armeniaca) on allergic asthma, mice were pre-treated by oral administration of the solution before antigen sensitization for 10 days and 20days. And 2 days later, mice were actively sensitized with a subcutaneous injection of ovalbumin and 13 days later, they were provoked with ovalbumin aerosols. The experimental groups were divided 6groups(10d1P, 10d2P, 10d4P, 20d1P, 20d2P and 20d4P) by meditation quantity and period. We measured isometric contractile responses to acetylcholine(ACh) and KCl in the isolated tracheal smooth muscle(TSM), IL-4, eosinophil and lymphocyte in bronchoalveolar lavage fluid(BALF), IgE in serum, WBC, RBC and hemoglobin in blood. Results: Contractile responses of TSM to ACh, the sensitivity of TSM to Ach and the maximal contractile response of TSM to KCl were decreased by direct proportion of meditation quantity. Eosinophil and IL-4 level in BALF were more significantly decreased, and IgE level in serum was more significantly increased in 10d4P and 20d4P group than the control group. Conclusions: Based on the above results, it is assumed that oral administration of the combination of phenolic compound extracted from pear and herbal drugs(Platycodon grandiflorum, Prunus armeniaca) can help the preventing effects of allergic asthma.

• 한국산학기술학회논문지
• /
• 제17권9호
• /
• pp.57-67
• /
• 2016

본 연구는 제 4기, 제 5기 국민건강영양조사 자료를 이용하여 18세 이상 성인 23577 명을 남성 전체와 여성 전체, 65세 이상 남성과 65세 미만 남성, 폐경 전 여성과 폐경 후 여성으로 나누어 비타민 D의 수준에 따라 헤모글로빈과 페리틴 농도의 변화가 어떤 차이를 보이는지 알아보고자 하였다. 각 조사 대상 군을 비타민 D의 수준에 따라 5분 위수로 나누어 각 군 별 헤모글로빈과 페리틴 농도의 변화를 복합표본설계방법에 따라 일반선형모형을 사용하여 분석하였고 분석 결과 여성 전체 군(p<0.001)과 폐경 전 여성 군(p<0.001)에서 비타민 D 수준에 따라 헤모글로빈 농도의 차이가 통계적으로 유의하였고 폐경 후 여성 군과 남성 전체 및 65세 이상 남성, 65세 미만 남성 군에서는 통계적으로 유의하지 않았다. 페리틴 농도는 여성 전체 군(p<0.001)과 폐경 전 여성 군(p<0.001)과 남성 전체 군(p<0.05), 65세 미만 남성 군(p<0.05))에서 통계적으로 유의한 차이를 나타냈으나 남성에서 비타민 D가 높은 그룹이 페리틴이 낮았던 반면 여성에서는 비타민 D가 높은 그룹이 페리틴 농도가 더 높았고, 폐경 후 여성 군과 65세 이상 군에서 통계적으로 유의하지 않았다. 따라서 비타민 D는 폐경 전 여성에서 헤모글로빈 농도에 영향을 줄 가능성이 있고 폐경 전 여성과 65세 미만 남성의 체내 철 조절에 관여할 가능성이 있다.

• 동의생리병리학회지
• /
• 제27권4호
• /
• pp.465-470
• /
• 2013

The purpose of this study is to observe clinically the effects of red onion prescription on type 2 diabetes. The subject of this study were middle-aged people. We measured clinically physiological index, body composition, radial arterial pulse wave before taking medicine and after taking medicine for 4 month (the prescription of red onion). The study results were as follows. In physiological Index, diastolic blood pressure(mmHg)(p<0.001), Fasting blood glucose(mg/dL)(p=0.001), and HbA1c(%)(p<0.001) were decreased significantly after taking medicine. In body Composition, waist-hip ratio(p=0.031), body fat percentage(p=0.006), fat mass(kg)(p=0.005), and muscle mass(kg)(p=0.001) were decreased significantly after taking medicine. Blood Circulation Index, ECO(L/min)(p=0.038) and ECI($L/min/m^2$)(p=0.007) were increased significantly after taking medicine, ECR($dyne^*sec^*cm^{-5}$)(p=0.002), and ECRI($dyne^*sec/cm$)(p=0.001) were decreased significantly after taking medicine for 4 month. The prescription of red onion was showed significant change in physiological index, character of body composition, blood circulation index. Based on this result, it is considered that red onion prescription has the positive effects on type 2 diabetes and blood circulation clinically. In the future, diversified studies on the effects of red onion prescription are needed.

• 한국안광학회지
• /
• 제18권3호
• /
• pp.305-311
• /
• 2013

목적: 간헐외사시의 비수술적 치료법들 중의 하나인 과교정 (-)렌즈 처방이 입체시와 사시각에 미치는 영향에 대해 연구하였다. 방법: 2011년 10월부터 2011년 12월까지 전남대학교 병원에서 간헐외사시로 진단받은 환자 24명을 대상으로 -1.00, -2.00, 그리고 -3.00 D의 단계적인 과교정 (-)렌즈를 착용하게 한 후 근거리(33 cm)와 원거리(6 m)에서 사시각(prism diopter, ${\Delta}$), 입체시(second of arc, arcsec), 양안시력(LogMAR), 사시조절능력(control of exodeviation) 및 워쓰4등검사를 이용한 융합력의 변화를 측정하였다. 결과: 과교정 전의 평균 사시각은 근거리 $20.9{\pm}9.7$ ${\Delta}$, 원거리 $23.0{\pm}7.5$ ${\Delta}$이다. -1.00, -2.00, -3.00 D의 (-)렌즈 착용 시 근거리 사시각은 각각 $18.5{\pm}10.0$ ${\Delta}$ (p<0.01), $15.8{\pm}9.0$ ${\Delta}$ (p<0.01), 그리고 $14.0{\pm}9.1$ ${\Delta}$ (p<0.01)로 의미 있게 감소하였으며, 원거리 사시각은 -2.00 D 및 -3.00D의 렌즈 착용 시 각각 $21.4{\pm}5.2$ ${\Delta}$ (p=0.01), $19.6{\pm}6.3$ ${\Delta}$ (p<0.01)으로 감소하였다. 이에 반하여 양안시력, 사시조절능력, 융합력, 입체시는 과교정 (-)렌즈를 처방하더라도 의미 있는 감소를 보이지 않고 유지되었다(p>0.05). 결론: 간헐외사시에서 과교정 (-)렌즈 처방은 근거리 및 원거리 외사시각을 줄일 수 있는 효과적인 방법이며 과교정 시 양안시력과 입체시는 감소하지 않고 유지됨을 알 수 있었다.

• 한국안광학회지
• /
• 제15권3호
• /
• pp.281-286
• /
• 2010

목적: 시험렌즈와 포롭터에서의 측정된 교정굴절력 변화를 비교하기 위하여 실시하였다. 방법: 시험렌즈와 포롭터를 사용했을 때의 교정굴절력을 비교하고, 굴절검사기기(시험렌즈와 포롭터)에 따른 구면렌즈교정굴절력, 원주렌즈 교정굴절력의 통계학적 유의성과 상관성, 난시안에서 난시량과의 굴절검사기기와의 상관성과 통계학적 유의성을 분석하였다. 결과: 단순근시안의 교정굴절력을 시험렌즈와 포롭터를 이용하여 측정한 결과 평균교정굴절력이 시험렌즈는 S-2.74D, 포롭터는 S-2.65D로, 포롭터로 측정했을 때의 교정굴절력이 약 0.09D 낮게 측정되었고, 난시량은 시험렌즈는 C-0.81D, 포롭터는 C-0.77D로, 포롭터를 이용하였을 때 약 0.04D 정도 낮게 측정되었다. 굴절검사기기(시험렌즈와 포롭터)와 교정굴절력과의 상관성 분석 결과, 굴절검사기기와 구면렌즈 교정굴절력은 r=0.996으로 높은 상관성이 있었고, 통계학적으로도 유의한 차이가 있었으며(p<0.01), 원주렌즈 교정굴절력도 r=0.986으로 높은 상관성이 있었고, 통계학적으로도 유의한 차이가 있었다(p<0.01). 결론: 고도비정시안(단순굴절이상과 고도 난시안)의 굴절검사는 시험렌즈보다는 포롭터를 이용하는 것이 바람직하고, 시험렌즈를 이용할 경우 처방 시 정점간거리나 렌즈사이의 간격에 주의가 요구 된다.

• 대한방사선기술학회지:방사선기술과학
• /
• 제25권1호
• /
• pp.63-71
• /
• 2002

The aim of this study Is to develop a simple and fast method which computes in-vivo doses from transmission doses measured doting patient treatment using an ionization chamber. Energy fluence and the dose that reach the chamber positioned behind the patient is modified by three factors: patient attenuation, inverse square attenuation. and scattering. We adopted a straightforward empirical approach using a phantom transmission factor (PTF) which accounts for the contribution from all three factors. It was done as follows. First of all, the phantom transmission factor was measured as a simple ratio of the chamber reading measured with and without a homogeneous phantom in the radiation beam according to various field sizes($r_p$), phantom to chamber distance($d_g$) and phantom thickness($T_p$). Secondly, we used the concept of effective field to the cases with inhomogeneous phantom (patients) and irregular fields. The effective field size is calculated by finding the field size that produces the same value of PTF to that for the irregular field and/or inhomogeneous phantom. The hypothesis is that the presence of inhomogeneity and irregular field can be accommodated to a certain extent by altering the field size. Thirdly, the center dose at the prescription depth can be computed using the new TMR($r_{p,eff}$) and Sp($r_{p,eff}$) from the effective field size. After that, when TMR(d, $r_{p,eff}$) and SP($r_{p,eff}$) are acquired. the tumor dose is as follows. $$D_{center}=D_t/PTF(d_g,\;T_p){\times}(\frac{SCD}{SAD})^2{\times}BSF(r_o){\times}S_p(r_{p,eff}){\times}TMR(d,\;r_{p,eff})$$ To make certain the accuracy of this method, we checked the accuracy for the following four cases; in cases of regular or irregular field size, inhomogeneous material included, any errors made and clinical situation. The errors were within 2.3% for regular field size, 3.0% irregular field size, 2.4% when inhomogeneous material was included in the phantom, 3.8% for 6 MV when the error was made purposely, 4.7% for 10 MV and 1.8% for the measurement of a patient in clinic. It is considered that this methode can make the quality control for dose at the time of radiation therapy because it is non-invasive that makes possible to measure the doses whenever a patient is given a therapy as well as eliminates the problem for entrance or exit dose measurement.

• 생물정신의학
• /
• 제8권2호
• /
• pp.208-219
• /
• 2001

The pharmacotherapy of schizophrenia exhibits wide inter-individual variabilities in clinical efficacy and adverse effects. Recently, human genetic diversity has been known as one of the essential factors to the variation in human drug response. This suggests that drug therapy should be tailored to the genetic characteristics of the individual. Pharmacogenetics is the field of investigation that attempts to elucidate genetic basis of an individual's responses to pharmacotherapy, considering drug effects divided into two categories as pharmacokinetics and pharmacodynamics. The emerging field of pharmacogenomics, which focuses on genetic determinants of drug response at the level of the entire human genome, is important for development and prescription of safer and more effective individually tailored drugs and will aid in understanding how genetics influence drug response. In schizophrenia, pharmacogenetic studies have shown the role of genetic variants of the cytochrome P450 enzymes such as CYP2D6, CYP2C19, and CYP2A1 in the metabolism of antipsychotic drugs. At the level of drug targets, variants of the dopamine $D_2$, $D_3$ and $D_4$, and 5-$HT_{2A}$ and 5-$HT_{2C}$ receptors have been examined. The pharmacogenetic studies in schizophrenia presently shows controversial findings which may be related to the multiple involvement of genes with relatively small effects and to the lack of standardized phenotypes. For further development in the pharmacogenomics of schizophrenia, there would be required the extensive outcome measures and definitions, and the powerful new tools of genomics, proteomics and so on.